Ral GTPases promote breast cancer metastasis by controlling biogenesis and organ targeting of exosomes

Ral GTP酶通过控制外泌体的生物合成和器官靶向来促进乳腺癌转移。

阅读:4
作者:Shima Ghoroghi ,Benjamin Mary ,Annabel Larnicol ,Nandini Asokan ,Annick Klein ,Naël Osmani ,Ignacio Busnelli ,François Delalande ,Nicodème Paul ,Sébastien Halary ,Frédéric Gros ,Laetitia Fouillen ,Anne-Marie Haeberle ,Cathy Royer ,Coralie Spiegelhalter ,Gwennan André-Grégoire ,Vincent Mittelheisser ,Alexandre Detappe ,Kendelle Murphy ,Paul Timpson ,Raphaël Carapito ,Marcel Blot-Chabaud ,Julie Gavard ,Christine Carapito ,Nicolas Vitale ,Olivier Lefebvre ,Jacky G Goetz # ,Vincent Hyenne #

Abstract

Cancer extracellular vesicles (EVs) shuttle at distance and fertilize pre-metastatic niches facilitating subsequent seeding by tumor cells. However, the link between EV secretion mechanisms and their capacity to form pre-metastatic niches remains obscure. Using mouse models, we show that GTPases of the Ral family control, through the phospholipase D1, multi-vesicular bodies homeostasis and tune the biogenesis and secretion of pro-metastatic EVs. Importantly, EVs from RalA or RalB depleted cells have limited organotropic capacities in vivoand are less efficient in promoting metastasis. RalA and RalB reduce the EV levels of the adhesion molecule MCAM/CD146, which favors EV-mediated metastasis by allowing EVs targeting to the lungs. Finally, RalA, RalB, and MCAM/CD146, are factors of poor prognosis in breast cancer patients. Altogether, our study identifies RalGTPases as central molecules linking the mechanisms of EVs secretion and cargo loading to their capacity to disseminate and induce pre-metastatic niches in a CD146-dependent manner.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。